SCCM Resource Library-The Use of Clinical Data to Inform and Identify the Potential New Value of Existing HDTs

The Use of Clinical Data to Inform and Identify the Potential New Value of Existing HDTs

Video Transcription

Video Summary

The presentation discusses CureID, a platform developed by the FDA and NIH to gather treatment experiences from clinicians and patients for conditions lacking effective options. It targets infectious diseases, critical care, and rare diseases by collecting data to inform drug repurposing. CureID utilizes electronic health record extraction and manual entries to capture real-world data. The initiative aims to identify potentially effective treatments from existing drugs, generating hypotheses for further research. Key partnerships and ongoing expansions aim to enhance data collection and support future clinical trials, focusing on areas like COVID-19 and sepsis.

Asset Caption

90-Minute Session | Clinical Evidence for Host-Directed Therapeutics

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

CureID

drug repurposing

real-world data

infectious diseases

clinical trials

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.